We do of course take the post‑COVID syndrome very seriously. We are investing in this area and working with partners to conduct studies on the syndrome. It is too early to say exactly what the long-term effects will be. Yet a study published a few days ago indicates that the risk of developing long COVID‑19 is much lower after being infected with the Omicron variant than the Delta variant. So there are a number of processes, and we are studying various permutations of the problem in order to address it.
